Key result
Cardiovascular disease is a major cause of morbidity in female cancer survivors, necessitating baseline risk assessment, long-term surveillance, and cardio-oncology collaboration.
Why the study?
CVD has emerged as a competing cause of morbidity and mortality among cancer survivors due to cancer therapies and shared risk factors, with disparities exacerbated when both conditions co-exist.
Answers are grounded in this paper and cite their sources.
Highlights the importance of a holistic, collaborative cardio-oncology approach to manage cardiovascular risk in female cancer survivors.
Improvements in cancer care have led to an exponential increase in cancer survival. This is particularly the case for breast cancer, where 5-year survival in Australia exceeds 90%. Cardiovascular disease (CVD) has emerged as one of the competing causes of morbidity and mortality among cancer survivors, both as a complication of cancer therapies and because the risk factors for cancer are shared with those for CVD. In this review we cover the key aspects of cardiovascular care for women throughout their cancer journey: the need for baseline cardiovascular risk assessment and management, a crucial component of the cardiovascular care; the importance of long-term surveillance for ongoing maintenance of cardiovascular health; and strong evidence for the beneficial effects of physical exercise to improve both cancer and cardiovascular outcomes. There is general disparity in cardiovascular outcomes for women, which is further exacerbated when both CVD and cancer co-exist. Collaboration between oncology and cardiac services, with an emergence of the whole field of cardio-oncology, allows for expedited investigation and treatment for these patients. This collaboration as well as a holistic approach to patient care and key role of patients' general practitioners are essential to ensure long-term health of people living with, during and beyond cancer.
No takes yet. Share an insight, caveat, or question.
Ray et al. (2023) conducted a review in Cardiovascular disease in cancer survivors. Cardiovascular disease is a major cause of morbidity in female cancer survivors, necessitating baseline risk assessment, long-term surveillance, and cardio-oncology collaboration.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: